🔒 WHO Revised Biosimilar Guidelines: Streamlined Regulation for Improved Global Access
WHO's 2022 revised guidelines eliminate the need for mandatory clinical efficacy studies for biosimilars when strong analytical and pharmaco…
Critical impact 20 min